M Voulgarelis
M Voulgarelis
Unknown affiliation
Verified email at med.uoa.gr
Cited by
Cited by
The risk of lymphoma development in autoimmune diseases: a meta-analysis
E Zintzaras, M Voulgarelis, HM Moutsopoulos
Archives of internal medicine 165 (20), 2337-2344, 2005
Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome
M Voulgarelis, UG Dafni, DA Isenberg, HM Moutsopoulos
Arthritis & Rheumatism: Official Journal of the American College of …, 1999
Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects
E Baimpa, IJ Dahabreh, M Voulgarelis, HM Moutsopoulos
Medicine 88 (5), 284-293, 2009
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment
S Giannouli, M Voulgarelis, PD Ziakas, AG Tzioufas
Annals of the rheumatic diseases 65 (2), 144-148, 2006
Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis
PD Ziakas, M Pavlou, M Voulgarelis
Obstetrics & Gynecology 115 (6), 1256-1262, 2010
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome
M Voulgarelis, AG Tzioufas
Nature Reviews Rheumatology 6 (9), 529, 2010
Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin
M Voulgarelis, SIG Kokori, JPA Ioannidis, AG Tzioufas, D Kyriaki, ...
Annals of the rheumatic diseases 59 (3), 217-222, 2000
Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias
AG Tzioufas, M Voulgarelis
Best Practice & Research Clinical Rheumatology 21 (6), 989-1010, 2007
Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome
M Voulgarelis, PD Ziakas, A Papageorgiou, E Baimpa, AG Tzioufas, ...
Medicine 91 (1), 1-9, 2012
Autoimmune hemolytic anemia in patients with systemic lupus erythematosus
SIG Kokori, JPA Ioannidis, M Voulgarelis, AG Tzioufas, HM Moutsopoulos
The American journal of medicine 108 (3), 198-204, 2000
Preliminary classification criteria for the cryoglobulinaemic vasculitis
S De Vita, F Soldano, M Isola, G Monti, A Gabrielli, A Tzioufas, C Ferri, ...
Annals of the rheumatic diseases 70 (7), 1183-1190, 2011
Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview
PD Ziakas, LS Poulou, GI Rokas, D Bartzoudis, M Voulgarelis
Journal of Thrombosis and Haemostasis 5 (3), 642-645, 2007
Is JAK2 V617F mutation more than a diagnostic index?: A meta-analysis of clinical outcomes in essential thrombocythemia
IJ Dahabreh, K Zoi, S Giannouli, C Zoi, D Loukopoulos, M Voulgarelis
Leukemia research 33 (1), 67-73, 2009
Toll-like receptors, tissue injury, and tumourigenesis
S Ioannou, M Voulgarelis
Mediators of Inflammation 2010, 2010
Type I and II interferon signatures in Sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis
A Nezos, F Gravani, A Tassidou, EK Kapsogeorgou, M Voulgarelis, ...
Journal of autoimmunity 63, 47-58, 2015
Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study
S Giannouli, M Voulgarelis, E Zintzaras, AG Tzioufas, HM Moutsopoulos
Rheumatology 43 (5), 626-632, 2004
Myelodysplasia‐associated autoimmunity: clinical and pathophysiologic concepts
M Voulgarelis, S Giannouli, K Ritis, AG Tzioufas
European journal of clinical investigation 34 (10), 690-700, 2004
Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes
CI Maratheftis, E Andreakos, HM Moutsopoulos, M Voulgarelis
Clinical Cancer Research 13 (4), 1154-1160, 2007
A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia
E Zintzaras, T Koufakis, PD Ziakas, P Rodopoulou, S Giannouli, ...
European journal of epidemiology 21 (7), 501-510, 2006
Long term remission of Sjögren’s syndrome associated aggressive B cell non-Hodgkin’s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide …
M Voulgarelis, S Giannouli, AG Tzioufas, HM Moutsopoulos
Annals of the rheumatic diseases 65 (8), 1033-1037, 2006
The system can't perform the operation now. Try again later.
Articles 1–20